Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase ...
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is ...
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
The Swedish national life science strategy was launched in December 2019, and it has now been updated with a new government ...
- Automation of complex in vitro model generation and quantification at scale - Brightfield and fluorescent imaging ...
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is characterised by an increased number of eosinophilic granulocytes in organs and in the bloodstream, ...
Cancercellers genetiska variation kan utnyttjas för få ut större effekt av redan godkända läkemedel, enligt en studie från ...
Okunniga, oseriösa och ibland kriminella aktörer är ett växande hot mot patientsäkerheten inom skönhetsingrepp i estetiskt ...
Okunniga, oseriösa och ibland kriminella aktörer är ett växande hot mot patientsäkerheten inom skönhetsingrepp i estetiskt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback